J.C. Osselaer

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

J.C. Osselaer, Jean‐Pierre Cazenave, M. Lambermont et al. · Vox Sanguinis · 2008 · 105 citations · Full text

Medicine, Hematology, Oncology +17

Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: a pilot study.

Véronique D’Hondt, Thierry Guillaume, Yves Humblet et al. · PubMed · 1994 · 17 citations

Medicine, Immunology, Oncology +17

The Molecular Basis of Antithrombin Deficiency in Belgian and Dutch Families

Willy Lissens, Sara Seneca, P. Capel et al. · Thrombosis and Haemostasis · 1998 · 13 citations

Medicine, Genetics, Molecular Genetics +17

Routine Use of Platelet Components Prepared with Photochemical Treatment (INTERCEPT Platelets™): Impact on Clinical Outcomes and Resources.

J.C. Osselaer, Chantal Doyen, N. Messe et al. · Blood · 2005 · 12 citations

Medicine, Hematology, Hemostasis +10

Amotosalen‐<scp>HC</scp>l‐<scp>UVA</scp> pathogen reduction does not alter poststorage metabolism of soluble <scp>CD</scp>40 ligand, Ox40 ligand and interkeukin‐27, the cytokines that generally associate with serious adverse events

Hind Hamzeh‐Cognasse, Sandrine Laradi, J.C. Osselaer et al. · Vox Sanguinis · 2014 · 10 citations · Full text

Medicine, Immunology, Hypersensitivity +16